Findings identify CD7 as an active driver of chemoresistance in AML through cytokine-responsive NF-κB signaling, and highlight CD7-associated pathways as potential therapeutic vulnerabilities in CD7⁺ AML.
Chen-Shuo Ren, Nan Shao, Ye Yuan et al.· Journal of Experimental &...· 0 citations
Activating mutations in FMS-like tyrosine kinase 3 (FLT3) drive aggressive acute myeloid leukemia (AML) and confer poor prognosis. Although FLT3 inhibitors have improved outcomes, their efficacy is frequently limited by microenvironment-mediated signaling and treatment-emergent resistance. XY0206 is a structurally opti...
Long Shen, Yang Yang, Cheng-Hua Xu et al.· Journal of Clinical Investig...· 0 citations
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) stands as a leading curative approach for AML in China. However, relapse remains a major challenge for patient survival, often occurring within six months post-transplant and ass...
A panoramic landscape of the human hematopoietic system is established and its lifelong behaviors are elaborated, in which a steady-state reference enabled the delineation of pathological hallmarks across hematological malignancies.
Xiao-Wei Xie, Lian-Shuo Li, Fang Hong et al.· Protein & Cell· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.